z-logo
open-access-imgOpen Access
Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy
Author(s) -
L Kappenberger
Publication year - 1999
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1053/eupc.1998.0024
Subject(s) - medicine , cardiology , refractory (planetary science) , obstructive cardiomyopathy , myotomy , heart failure , angina , hypertrophic cardiomyopathy , surgery , myocardial infarction , achalasia , esophagus , physics , astrobiology
The therapeutic options for hypertrophic obstructive cardiomyopathy (HOCM) classically include medical treatment with beta-blockers and calcium antagonists or myectomy-myotomy as a surgical possibility for refractory cases. The observation that pacemaker activation of the heart in HOCM reduces the subaortic gradient is well known but less well investigated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom